Field trials to assess resistance to warfarin and difenacoum of house mice in relation to the occurrence of variants in the vkorc1-gene before and after the treatments by Endepols, S. et al.
 8th European Vertebrate Pest Management Conference 
70 Julius-Kühn-Archiv, 432, 2011 
Field trials to assess resistance to warfarin and difenacoum of house mice in relation to the 
occurrence of variants in the vkorc1-gene before and after the treatments 
Endepols, S.1, Klemann, N.2, Song, Y.3, Kohn, M.H.3  
1Bayer CropScience AG - Environmental Science - Innovations, 40789 Monheim, Germany, 
stefan.endepols@bayer.com 
2Warendorf, Germany 
3Rice University, Houston, USA 
DOI: 10.5073/jka.2011.432.035 
Abstract 
House mice (Mus musculus domesticus) vary considerably in their susceptibility to anticoagulants, and 
several non-synonymous sequence variants in the coding region of the vitamin K epoxide reductase 
subcomponent 1 gene (vkorc1) were found in Germany (Rost et al., 2009). It was the aim of our study to 
characterize the degree of resistance in relation to vkorc1genotypes in local mouse groups, and to test 
whether certain genotypes were selected by sequential treatments with the two anticoagulant rodenticides 
warfarin and difenacoum. 
Two successive treatments were conducted, the first with bait containing warfarin followed by a second 
using difenacoum. Their effects were determined on local sub-groups of mouse infestations in different 
sub-units on two livestock farms in Westphalia, Germany. The frequency of different vkorc1 genotypes, 
as determined by Sanger sequencing, was considered relative to the rodenticide treatment results for each 
sub-group and sampling period. 
Three tolerance types were identified on farm one: A=warfarin-susceptible, B=resistant to warfarin, but 
susceptible to difenacoum, C=approx. one half of animals resistant to both anticoagulants. On farm 2, 
only type A and B were identified. A high degree of resistance was observed in vkorc1 wild-type mice. 
In all cases, only the R58G vkorc1 variant was found, which appears not to be a resistance marker in 
house mice. Hence, in these mouse infestations, practical resistance to anticoagulants was not 
accompanied by any identifiable vkorc1 resistance marker. 
The study was funded by the Rodenticide Resistance Action Committee (RRAC) of CropLife 
International. 
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Introduction  
House mice (Mus musculus domesticus) vary considerably in their susceptibility to anticoagulants. In 
contrast to rats (Rattus norvegicus) in Northern Germany, where virtually all anticoagulant resistant rats 
carry a Y139C mutation in vitamin K epoxide reductase subcomponent 1 gene (vkorc1), several other 
non-synonymous coding sequence variants of the vkorc1 appear to segregate in mouse populations from 
Germany including the Y139C variant (Rost et al., 2009). However, with the exception of the Y139C 
mutation, little information from field studies is available on the susceptibility to anticoagulants in mouse 
strains marked by these variants, and on the effect of practical treatments with rodenticides. In the 
present study, the effectiveness of two anticoagulant rodenticides was investigated in two populations of 
the house mouse suspected to harbor resistant animals. Genetic analysis of vkorc1 was used to provide 
information about type and frequency of vkorc1 sequence variants occurring in sub-units of the 
populations before and after the treatments. The aim was to characterize the degree of resistance in 
relation to genotypes in local mouse groups, and to test whether certain vkorc1 genotypes were selected 
by the treatments, i.e. increased or decreased in allele frequency as a result of rodenticide use. 
The study was funded by the Rodenticide Resistance Action Committee (RRAC) of CropLife 
International and MHK and YS were partially funded by National Institute of Health grant R01. 
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Materials and Methods 
Two successive treatments with anticoagulant rodenticides were conducted and monitored for their effect 
on local sub-groups of mouse infestations in the different sub-units on two livestock farms in Westphalia, 
Germany. Grain baits containing 0.05% warfarin for the first treatment, and 0.005% difenacoum for the 
second treatment, were systematically distributed at certain structural elements according to the standard 
rodent control program BayTool for 28 days (www.baytool.info). Bait consumption was recorded during 
regular visits to the treated sites, and the effect of the treatments was determined by census baiting. Mice 
were trapped prior to, between the two treatments, and after the treatments for tissue sampling (tail clips). 
Since most non-synonymous mutations of vkorc1 in mice were found in the first and third exons (Rost et 
al., 2009), the two segments were amplified using the primers and conditions described in Song et al. 
(2008). All PCR products were cleaned by ExoSAP-IT (USB, Cleveland, OH) and sequenced with the 
Sanger-method for the detection of coding sequence variants in the gene. The frequency of vkorc1 
genotypes was put into relation to the rodenticide treatment results for each sub-group and sampling 
period. 
Results 
Mice consumed 3.0 kg of warfarin bait and 1.2 kg of difenacoum bait during the first trial, and 3.7 kg 
and 1.6 kg respectively of the two baits during the second trial. The level of resistance differed markedly 
between sub-units on both farms (Table 1). Three tolerance types were identified on farm one: 
A=warfarin-susceptible, B=resistant to warfarin, but susceptible to difenacoum, C=approx. one half of 
animals resistant to both anticoagulants. On farm 2, only type A and B were identified. 
Tab. 1 Results of anticoagulant treatments according to sub-units in 2 trial sites. 
Site 1 Site 2 
Tolerance type Survival rate (%) Tolerance type Survival rate (%) 
(sub-unit No.) Warfarin Difenacoum (sub-unit No.) Warfarin Difenacoum 
A (1)   7.2      0 A (1)     7.1    0 
B (2) 92.9      0 B (2) 104.0 7.2 
C (3) 59.3 94.5 B (3)   92.0 5.7 
 
We obtained vkorc1 sequences for 41 mice on farm 1 and 54 mice on farm 2. Only one non-synonymous 
mutation R58G was found in exon 1 in all the sequenced mice from the two farms. On farm 1 almost all 
mice (n=39) were vkorc1 wild-type, and only 2 mice carried the heterozygous mutation R58G (i.e. allele 
frequency 2.4%). On farm 2, all mice were homozygous for R58G in tolerance type A (n =18, warfarin-
susceptible, sub-unit 1). 12 mice trapped in sub-unit 2+3 were wild-type, 6 were homozygous and 18 
were heterozygous for R58G. Thus, we observed a high degree of resistance in vkorc1 wild-type mice. 
Only the R58G vkorc1 variant was found, which appears not to be a resistance marker in house mice.  
Discussion 
Resistance to warfarin was present in both mouse populations studied. Resistance to difenacoum 
occurred only in one sub-unit on one farm. Even there, no vkorc1 variant was found that could explain 
vkorc1-mediated resistance, at least at the level of protein coding mutations. We therefore conclude that 
resistance to anticoagulants can be manifested in field populations of mice without the presence of 
vkorc1 coding mutations. In addition to the comparatively well-understood vkorc1-mediated resistance 
(e.g., Y139C variant), our results suggest the possible involvement of other genes and/or other genetic 
mechanisms (e.g., gene regulatory or epigenetic changes) in anticoagulant resistance in mice. It is also 
conceivable that food rich in vitamin K mediated a fully or partially non-genetic form of resistance. 
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